Determination of voglibose in pharmaceutical formulations by high performance liquid chromatography using refractive index detection
Open Access
- 31 December 2010
- journal article
- Published by European Journal of Chemistry in European Journal of Chemistry
- Vol. 1 (4), 262-265
- https://doi.org/10.5155/eurjchem.1.4.262-265.116
Abstract
Voglibose is a potent glucosidase inhibitor used for type II diabetes mellitus. A simple and rapid high performance liquid chromatographic method with refractive index detection was developed for the determination of voglibose in pharmaceutical formulations. Development was performed on a C18 (250 x 4.6 mm, 5 µ) column using a mobile phase mixture of acetonitrile and water in the ratio of 50:50 which was fixed at a flow rate of 0.5 mL/min. Polarity of voglibose was found to be positive and elution time was found to be less than 5 min. The method was also validated as per ICH guidelines for its linearity, precision, accuracy and robustness. The limit of detection and quantification (LOD and LOQ) were found to be 2.91 and 9.7 µg/mL. The method could be successfully applied for the quantification of voglibose in pharmaceutical formulations.Keywords
This publication has 8 references indexed in Scilit:
- Quantitative determination of voglibose in pharmaceutical tablets using high-performance liquid chromatography–fluorescence detection with post-column derivatization and mass spectrometric detectionJournal of Pharmaceutical and Biomedical Analysis, 2006
- Voglibose (Basen®, AO-128), One of the Most Important α-Glucosidase InhibitorsCurrent Medicinal Chemistry, 2006
- α-Glucosidase inhibitor reduces the progression of carotid intima-media thicknessDiabetes Research and Clinical Practice, 2005
- Multi-objective optimisation strategy based on desirability functions used for chromatographic separation and quantification of l-proline and organic acids in vinegarAnalytica Chimica Acta, 2005
- Determination of the structures of four new isomeric cyclitolsCarbohydrate Research, 2004
- Different effects of two α-glucosidase inhibitors, acarbose and voglibose, on serum 1,5-anhydroglucitol (1,5AG) levelJournal of Diabetes and its Complications, 2004
- Efficacy and safety of voglibose in comparison with acarbose in type 2 diabetic patientsDiabetes Research and Clinical Practice, 2002
- Analysis of the antidiabetic drug acarbose by capillary electrophoresisJournal of Chromatography B: Biomedical Sciences and Applications, 1997